SCHEMBL17526593

SCHEMBL17526593

CCCCC[C@H](CO)CCCC

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.90
ALDH1A1 P00352 4/20 0.71
CYP2D6 P10635 2/20 0.46
CYP3A4 P08684 2/20 0.46
SPHK1 Q9NYA1 1/20 0.46
GMNN O75496 1/20 0.46
POLB P06746 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
BLM P54132 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
MAPT P10636 1/20 0.46
CETP P11597 1/20 0.46
HTT P42858 1/20 0.46
UBE2N P61088 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
DNM1 Q05193 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17526764 1.00 LMNA (0.90) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL744748 1.00 LMNA (0.90) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL15936480 1.00 LMNA (0.90) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL22129666 0.97 LMNA (0.95) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL22129709 0.97 LMNA (0.95) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL9442816 0.97 LMNA (0.95) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL5566930 0.97 LMNA (0.95) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL21561335 0.97 LMNA (0.95) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL3093827 0.97 LMNA (0.95) LMNAALDH1A1CYP2D6CYP3A4SPHK1
SCHEMBL22129707 0.97 LMNA (0.95) LMNAALDH1A1CYP2D6CYP3A4SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 LMNA 3497/4885ALDH1A1 2376/4885CYP2D6 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.